InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,291.29
(
0.32%
)
Post# of 14825
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

coinstarz

Send PM Follow Ignore
Followers 16
Posts 2682
Boards Moderated 0
Alias Born 09/16/2004

coinstarz

Re: None

Tuesday, 02/28/2006 1:17:23 PM

Tuesday, February 28, 2006 1:17:23 PM

Post# of 14825
Review Schedule of final decision.

According to company's PR "BDA has completed an initial review of the application and deems the application to be sufficiently complete and in compliance with regulations to allow the application to advance into the formal review process...",

Review of HIV aware OMT 1/2 has been in prograss for 22 working days now (started Jan 16 and excluding 2 weeks holiday).

The total formal review process requires not more than 35 working days (plus 10 working day for delivering if not use fax) according to BDA. Or 60-70 calendar days in total.

Therefore, the next two weeks are very important for Calypte regarding BDA decision and AMEX hearing.

I think BDA will approve HIV aware OMT 1/2 in March. This is my opinion.


http://biz.yahoo.com/prnews/060112/nyth034a.html?.v=1
http://www.sfda.gov.cn/eng/





Peace!

C-Starz

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up